Asthma Update: From the Basics to the Biologics
-
Register
- User - $40
Most patients with asthma are managed by primary care providers and not by specialists. This session will summarize the advances in the evaluation and management of asthma from basics to biologics using updated 2021 GINA guidelines. Treatment of difficult asthma, especially severe asthma and asthma/COPD overlap will be discussed. Management of asthma during the covid19 pandemic will be reviewed. Use of personalized medicine with biologics and new drugs in development for asthma will be reviewed. The challenges of delivering healthcare in rural and other environments with lower access to resources will be incorporated in all treatment approaches.
Credits: 1.50 contact hours; 1.50 are pharmacology
Expiration Date: December 31, 2024
$40.00
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Conduct a comprehensive evaluation of asthma severity and control.
-Use current evidence-based strategies to manage asthma in the primary care setting.
-Consider role of advanced therapies to manage severe, refractory asthma, Asthma/COPD overlap syndrome (ACOS) and COVID-19.
Sohera Syeda, MD
Assistant Professor, Physician
Boston University
Dr. Syeda is an Assistant Professor at Boston University School of Medicine’s Section of Pulmonary, Critical Care Section and holds a Lecturer of Medicine appointment at the Harvard Medical School. She is a practicing physician at the VA Boston in West Roxbury, MA and Bedford VA in Bedford, MA. She is on staff at Steward Norwood Hospital’s intensive care unit in Norwood, MA and works in the tele-ICU for the Steward Hospital System in Massachusetts. She serves as a consultant to the Boston University School of Medicine, Barry M. Manuel Office of Continuing Medical Education and COPD Quality Improvement Consortium and has engaged in several collaborative COPD QI projects. She has presented on several pulmonary topics including COPD, asthma, smoking cessation, e-cigarettes/vaping and COVID19 at in-person and virtual NPACE conferences over the past four years.
Dr. Syeda received her MD in 2005 in at Rush University Medical Center and completed residency and Chief Residency in Internal Medicine at Boston University School of Medicine. She completed a Pulmonary & Critical Care Fellowship and conducted health services research focusing on the impact of prolonged mechanical ventilation and use of tracheostomy on chronic critical illness at Boston University. She is ABIM board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine.
At the Boston VA, Dr. Syeda is engaged in various clinical, educational and administrative initiatives. She regularly teaches medical students, residents and fellows at Boston VA and is actively engaged in various hospital initiatives to improve transitional care and reduce admissions and readmissions for patients with COPD and Heart Failure. To this end, she developed and served as a medical director of a successful intensive care and case management program for veterans with advanced COPD and heart failure. More recently, she has actively been involved in treating Covid19 patients in telehealth, ambulatory and intensive care settings.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Sohera Syeda, MD have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
